与结直肠癌相关的突变会损害EphB1激酶的功能
Yunyoung Kim1, Sultan Ahmed1, W Todd Miller2
1Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, USA.
The Journal of biological chemistry
|August 1, 2023
概括
在EphB1中发生的突变,受体氨酸激酶,降低其活性和瘤抑制功能在结肠直肠癌 (CRC). 这些EphB1突变损害了细胞迁移和细分,这表明在CRC进展中发挥了作用.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 产生红素的肝瘤 (Eph) 受体氨酸激酶对细胞迁移和在发育中的粘附以及组织恒温至关重要.
- 在肠上皮层中,Eph信号决定了细胞沿着密室-维卢斯轴的位置.
- 埃菲活性已经证明了对结直肠癌 (CRC) 进展的瘤抑制潜力.
研究的目的:
- 研究结直肠癌中与癌症相关的EphB1突变的功能后果.
- 阐明EphB1突变影响其激酶活性,稳定性和信号通路的分子机制.
- 确定EphB1突变对CRC细胞行为的影响,包括迁移和细分.
主要方法:
- 纯化野生类型 (WT) 和五种与癌症相关的突变EphB1激酶域.
- 开发生物化学测试以评估EphB1活性和蛋白质稳定性.
- 哺乳动物细胞表达系统用于评估信号通路调制 (STAT3,ERK1/2) 和细胞迁移/细分测试.
主要成果:
- 发现与CRC相关的EphB1突变降低了激酶活性并破坏了蛋白质的折叠结构的稳定性.
- 突变的EphB1受体抑制了STAT3和ERK1/2信号通路,与WT EphB1.1不同.
- 突变的EphB1受体未能抑制人类CRC细胞迁移和受损的细胞细分.
结论:
- 在EphB1体质突变减少其酶依赖的瘤抑制功能在结肠直肠癌.
- 由于突变而导致的EphB1活动受损可能会通过影响细胞迁移和组织来促进CRC进展.
- 了解这些突变可以了解针对CRC中的EphB1的新型治疗策略.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K


